Inventor · disambiguated record
Cassandra Celatka
Also filed as: CELATKA CASSANDRA · CELATKA CASSANDRA A
19 granted patents·12 pending applications·111 citations·filing 2006–2024
94Inventor score
Top patents by PatentIndex Score
31 records- 0195US10519118B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2018·Granted Dec 31, 2019·8 cites·22 claims
- 0293US11230534B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Jan 25, 2022·4 cites·10 claims
- 0393US9981922B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2016·Granted May 29, 2018·11 cites·9 claims
- 0492US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 0590US8304447B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2008·Granted Nov 6, 2012·18 cites·20 claims
- 0688US8309593B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2009·Granted Nov 13, 2012·15 cites·15 claims
- 0787US8940776B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Jan 27, 2015·11 cites·19 claims
- 0887US7501404B2Substituted azetidinonesDAIMED·Filed 2006·Granted Mar 10, 2009·21 cites·17 claims
- 0986US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 1084US11578059B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Feb 14, 2023·2 cites·30 claims
- 1184US11390590B2Methods and processes for the preparation of KDM1A inhibitorsIMAGO BIOSCIENCES INC·Filed 2017·Granted Jul 19, 2022·3 cites·28 claims
- 1282US9272996B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Mar 1, 2016·6 cites·16 claims
- 1382US2025026749A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2024·Application pending·0 cites
- 1479US9745294B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Aug 29, 2017·3 cites·24 claims
- 1577US11773068B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2021·Granted Oct 3, 2023·0 cites·5 claims
- 1676US11932629B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2022·Granted Mar 19, 2024·0 cites·21 claims
- 1772US9744153B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2016·Granted Aug 29, 2017·1 cites·14 claims
- 1872US2021261557A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 1971US2023104647A1Methods and processes for the preparation of kdm1a inhibitorsIMAGO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2066US8633168B2Inhibitors of S-adenosyl-L-methionine decarboxylaseXIANG YIBIN·Filed 2008·Granted Jan 21, 2014·1 cites·18 claims
- 2164US2020048266A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 2261US2025032454A1Kdm1a inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2361US2009143351A1Substituted azetidinonesDAIAMED·Filed 2009·Application pending·0 cites
- 2460US2023293495A1Pharmaceutical formulations for treating diseases mediated by kdm1aIMAGO BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2557US2015210681A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Application pending·0 cites
- 2657US2018093981A12-Acylaminopropoanol-Type Glucosylceramide Synthase InhibitorsGENZYME CORP·Filed 2017·Application pending·0 cites
- 2753US2016207933A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2015·Application pending·0 cites
- 2845US2010144698A1Substituted azetidinonesDAIAMED·Filed 2010·Application pending·0 cites
- 2944US8703811B2Small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenaseBASTOS CECILIA·Filed 2009·Granted Apr 22, 2014·0 cites·11 claims
- 3043US2022025424A1Compositions and methods for producing stereoisomerically pure aminocyclopropanesIMAGO BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 3132US8980926B22-aminoindole compounds and methods for the treatment of malariaMAZITSCHEK RALPH·Filed 2010·Granted Mar 17, 2015·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →